Statins Improve Survival in Leukaemia and Lymphoma Patients on Ibrutinib

LLS | People with CLL are living longer than ever before

People with CLL are living longer than ever before, and cures are on the horizon difilippob Fri, 05/02/2025 - 14:11 People with the most common type of blood cancer, chronic lymphocytic leukemia (CLL), are living longer than ever before without their disease progressing. While cures for CLL patients are still rare, survival rates have improved steadily over the last 50 years, with nearly 90 percent of people diagnosed with CLL today surviving at…

CLL & Statins: A Surprising Link

Ahmad Abuhelwa, MD, discusses the mechanisms of statins and how they can play a surprisingly beneficial role in patients with chronic lymphocytic leukemia.

Statins Improve Survival in Leukaemia and Lymphoma Patients on Ibrutinib

A new study finds that statin use significantly improves survival outcomes in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma treated with ibrutinib, without increasing severe side effects.